Sumitomo Dainippon Pharma Aktie
4,56EUR | 0,06EUR | 1,33% |
WKN: 858257 / ISIN: JP3495000006
Personal
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 6 822 | 6 987 | 6 250 | 4 980 | 0 |
Umsatz pro Mitarbeiter in Mio. EUR | 75,63 | 80,15 | 88,89 | 63,16 | 0,00 |
Bilanz (in Mio. JPY) - Aktiva
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 459 795 | 499 521 | 381 860 | 269 569 | 253 168 |
Summe Anlagevermögen | 848 332 | 808 486 | 752 882 | 637 937 | 489 436 |
Summe Aktiva | 1 308 127 | 1 308 007 | 1 134 742 | 907 506 | 742 604 |
Bilanz (in Mio. JPY) - Passiva
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Summe Fremdkapital | 659 949 | 634 438 | 727 960 | 751 370 | 573 125 |
Summe Eigenkapital | 648 178 | 673 569 | 406 782 | 156 136 | 169 479 |
Summe Passiva | 1 308 127 | 1 308 007 | 1 134 742 | 907 506 | 742 604 |
Adresse
2-6-8 Dosho-machi, 541-0045 Osaka | |
Telefon | +81 (6) 6203-5321 |
Fax | +81 (6) 6202-6028 |
Internet | http://www.ds-pharma.co.jp/ |
Management
Hiroshi Niinuma
Non-Executive Director |
Hiroyuki Baba
Managing Executive Officer & Head-Legal Affairs |
Hisayoshi Kashima
Manager-Accounting |
Isao Shimizu
Executive Officer & Senior Research Director |
Kazuo Koshiya
Managing Executive Officer |
Kenji Ueno
Executive Officer & GM-Technology Research |
Koji Fujimoto
Outside Director |
Minoru Usui
Outside Director |
Motoyuki Sakai
Representative Director & VP-Governance |
Nobuhiro Endo
Independent Outside Director |
Saeko Arai
Independent Outside Director |
Shigeyuki Nishinaka
Managing Executive Officer |
Takashi Kutsunai
Auditor |
Takuya Taguchi
Managing Executive Officer & General Manager-Sales |
Toru Kimura
President, CEO & Representative Director |
Tsutomu Nakagawa
Director & Managing Executive Officer |
Yoshiharu Ikeda
Head-Research & Technology |
Yoshinori Ooe
Auditor |
Yutaka Wakemi
Executive Officer, VP & Head-Global Strategy |